Data / Form D filings / ALIMERA SCIENCES INC
ALIMERA SCIENCES INC: Form D filings
ALIMERA SCIENCES INC, a pharmaceuticals company in Alpharetta, GA, filed 7 Form D notices with the SEC between 2009 and 2023. The latest, on May 31, 2023, reports $81 million sold of a $81 million offering to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6310 Town Square, Suite 400, Alpharetta, GA, 30005
- Phone
- (678) 990-5740
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $25,000,001 - $100,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1267602
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 31, 2023 | Amendment | $81,000,000 | $81,000,000 | 16 | Mar 24, 2023 | sec.gov | |
| Apr 7, 2023 | New notice | $27,000,000 | $12,000,000 | $15,000,000 | 4 | Mar 24, 2023 | sec.gov |
| Apr 27, 2021 | New notice | $10,000,000 | $10,000,000 | 1 | Apr 14, 2021 | sec.gov | |
| Feb 18, 2014 | New notice | $37,500,000 | $37,500,000 | 21 | Jan 31, 2014 | sec.gov | |
| Oct 5, 2012 | New notice | $40,000,000 | $40,000,000 | 0 | Oct 2, 2012 | sec.gov | |
| May 25, 2011 | New notice | $332,486 | $332,486 | 0 | May 16, 2011 | sec.gov | |
| Sep 4, 2009 | New notice | $5,000,000 | $5,000,000 | 25 | Aug 25, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Adam S. Morgan | Director | |
| David S. Holland | Executive Officer | |
| Erin S. Parsons | Director | |
| Richard S. Eiswirth, Jr. | Executive Officer, Director | |
| Russell S. Skibsted | Executive Officer | |
| John J. Snisarenko | Director | |
| Michael S. Kaseta | Director | |
| Garheng S. Kong | Director | |
| Philip S. Ashman | Executive Officer | |
| Daniel S. Myers | Director | |
| Peter J. Pizzo III | Director |
Other pharmaceuticals companies in Georgia that filed recently
- Laurentide Therapeutics Inc. $99,999 · Sep 28, 2026
- LifeCyte Innovations, Inc. $1 million · Aug 20, 2026
Every Form D from the week of May 29, 2023 · All recent filings in Georgia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ALIMERA SCIENCES INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.